Nextech Invest Ag Mersana Therapeutics, Inc. Transaction History
Nextech Invest Ag
- $536 Million
- Q4 2024
A detailed history of Nextech Invest Ag transactions in Mersana Therapeutics, Inc. stock. As of the latest transaction made, Nextech Invest Ag holds 12,067,246 shares of MRSN stock, worth $6.27 Million. This represents 3.22% of its overall portfolio holdings.
Number of Shares
12,067,246
Previous 12,067,246
-0.0%
Holding current value
$6.27 Million
Previous $22.8 Million
24.34%
% of portfolio
3.22%
Previous 3.72%
Shares
4 transactions
Others Institutions Holding MRSN
# of Institutions
136Shares Held
101MCall Options Held
77.2KPut Options Held
453K-
Eco R1 Capital, LLC San Francisco, CA11.3MShares$5.89 Million0.76% of portfolio
-
Vr Adviser, LLC New York, NY10.3MShares$5.33 Million2.42% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA8.66MShares$4.51 Million3.35% of portfolio
-
Black Rock Inc. New York, NY8.38MShares$4.36 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.06MShares$3.67 Million0.0% of portfolio
About Mersana Therapeutics, Inc.
- Ticker MRSN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,169,296
- Market Cap $50.5M
- Description
- Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...